WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009058924) CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/058924    International Application No.:    PCT/US2008/081670
Publication Date: 07.05.2009 International Filing Date: 30.10.2008
IPC:
A61K 31/454 (2006.01), C07D 211/32 (2006.01), C07D 403/02 (2006.01)
Applicants: GLAXOSMITHKLINE LLC [US/US]; One Franklin Plaza, 200 North 16th Street Philadelphia, PA 1902 (US) (For All Designated States Except US).
KAZMIERSKI, Wieslaw, Mierczyslaw [US/US]; (US) (For US Only).
CHONG, Pek, Yoke [MY/US]; (US) (For US Only)
Inventors: KAZMIERSKI, Wieslaw, Mierczyslaw; (US).
CHONG, Pek, Yoke; (US)
Agent: BRINK, Robert, H.; c/o GlaxoSmithKline Corporate Intellectual Property Dept. Five Moore Drive P. O. Box 13398 Research Triangle Park, North Carolina 27709 (US)
Priority Data:
60/984,076 31.10.2007 US
Title (EN) CCR5 ANTAGONISTS AS THERAPEUTIC AGENTS
(FR) ANTAGONISTES DE CCR5 EN TANT QU'AGENTS THÉRAPEUTIQUES
Abstract: front page image
(EN)The present invention relates to compounds useful in the treatment of CCR5-related diseases and disorders, for example, useful in the inhibition of HIV replication, the prevention or treatment of an HIV infection, and in the treatment of the resulting acquired immune deficiency syndrome (AIDS).
(FR)L'invention concerne des composés utiles dans le traitement de maladies et troubles liés au CCR5, par exemple utiles dans l'inhibition de la réplication du VIH, la prévention ou le traitement de l'affection par le VIH et dans le traitement du syndrome d'immunodéficience acquise (SIDA) résultant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)